LAUSR

Due to the reduced absorption, light scattering, and tissue autofluorescence in the NIR‐II (1000–1700 nm) region, significant efforts are underway to explore diverse material platforms for in vivo fluorescence imaging, particularly for cancer diagnostics and image‐guided interventions. Of the reported imaging agents, nanoparticles derived from conjugated polymers (CPNs) offer unique advantages to alternative materials including biocompatibility, remarkable absorption cross‐sections, exceptional photostability, and tunable emission behavior independent of cell labeling functionalities. Herein, the current state of NIR‐II emitting CPNs are summarized and structure–function–property relationships are highlighted that can be used to elevate the performance of next‐generation CPNs. Methods for particle processing and incorporating cancer targeting modalities are discussed, as well as detailed characterization methods to improve interlaboratory comparisons of novel materials. Contemporary methods to specifically apply CPNs for cancer diagnostics and therapies are then highlighted. This review not only summarizes the current state of the field, but offers future directions and provides clarity to the advantages of CPNs over other classes of imaging agents.